SCHEMBL17325511

SCHEMBL17325511

CNc1cc(-c2cn([S+]([O-])c3ccccc3)c3ncccc23)nc(N)n1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NUDT1 P36639 7/20 0.41
▸ TYK2 P29597 1/20 0.35
▸ BPTF Q12830 1/20 0.35
▸ PDPK1 O15530 5/20 0.34
▸ ROCK1 Q13464 2/20 0.34
▸ DYRK1A Q13627 2/20 0.34
▸ GSK3B P49841 2/20 0.34
▸ CDC7 O00311 1/20 0.34
▸ DAPK3 O43293 1/20 0.34
▸ PRKD3 O94806 1/20 0.34
▸ MAP4K4 O95819 1/20 0.34
▸ PAK4 O96013 1/20 0.34
▸ PIM1 P11309 1/20 0.34
▸ PRKACA P17612 1/20 0.34
▸ GRK5 P34947 1/20 0.34
▸ MAP2K2 P36507 1/20 0.34
▸ MAPK8 P45983 1/20 0.34
▸ CSNK1A1 P48729 1/20 0.34
▸ CDK8 P49336 1/20 0.34
▸ CLK2 P49760 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20620223 0.85 NUDT1 (0.44) NUDT1PDPK1ROCK1DYRK1AAURKA
SCHEMBL17325525 0.85 NUDT1 (0.44) NUDT1PDPK1ROCK1DYRK1AAURKA
SCHEMBL20620222 0.81 DYRK1A (0.50) NUDT1TYK2BPTFPDPK1ROCK1
SCHEMBL15757624 0.76 HTR6 (0.44) NUDT1TYK2BPTFCDK8
SCHEMBL17325627 0.76 AGPAT2 (0.40) NUDT1PDPK1ROCK1AURKATGFBR1
SCHEMBL15757681 0.69 BPTF (0.67) NUDT1BPTFPDPK1ROCK1DYRK1A
SCHEMBL21317804 0.67 ELANE (0.39) TGFBR1
SCHEMBL17325531 0.67 NUDT1 (0.44) NUDT1PDPK1ROCK1AURKATGFBR1
SCHEMBL3354801 0.67 AKT1 (0.37) GSK3BPIM1ALKAURKATGFBR1
SCHEMBL15757522 0.66 GPR39 (0.54) NUDT1PDPK1ROCK1AURKATGFBR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015187089-A1 MTH1 INHIBITORS FOR TREATMENT OF INFLAMMATORY AND AUTOIMMUNE CONDITIONS THOMAS HELLEDAYS STIFTELSE FÖR MEDICINSK FORSKNING (SE) 2015-12-10 — — WO disclosed
Send feedback